Home » Authors » Anette Breindl

Anette Breindl

Articles

ARTICLES

More Vasculature Is Less Tumor In Genentech, Regeneron Papers

Dec. 27, 2006

By Anette Breindl

3D Mouse Brain Map Shows iPods Of Data In Each Gene

Dec. 26, 2006

By Anette Breindl

3D Mouse Brain Map Shows iPods Of Data In Each Gene

Dec. 26, 2006

By Anette Breindl

Exclusive Club' Of Noncoding RNA Now Open To 21U Crowd

Dec. 22, 2006

By Anette Breindl

Exclusive Club' Of Noncoding RNA Now Open To 21U Crowd

Dec. 22, 2006

By Anette Breindl

Research Suggests That For Angiogenesis, It's In The Mix

Dec. 13, 2006

By Anette Breindl

Research Suggests That For Angiogenesis, It's In The Mix

Dec. 13, 2006

By Anette Breindl

At ASH, Third-Generation Kinase Inhibitors For CML

Dec. 12, 2006

By Anette Breindl

At ASH, Third-Generation Kinase Inhibitors For CML

Dec. 12, 2006

By Anette Breindl

Double Trouble: Malaria, HIV Infection Feed Each Other

Dec. 11, 2006

By Anette Breindl

View All Articles by Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 9, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.